Brain injury contributes to dopaminergic neurodegeneration, Lewy body pathology, and Parkinsonism preclinically with outcomes altered by T cell modulation
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Mild traumatic brain injury (mTBI) exacerbates Parkinson's disease (PD) pathology by promoting neuroinflammation and alpha-synuclein spread. Reducing T and B cell infiltration into the brain improved outcomes for dopamine neurons.
Area Of Science
- Neuroscience
- Immunology
- Neurology
Background
- Traumatic brain injury (TBI) is a known risk factor for developing Parkinson's disease (PD).
- The precise mechanisms linking TBI to PD pathogenesis remain unclear.
- Neuroinflammation and immune system activation are implicated in both TBI and PD.
Purpose Of The Study
- To investigate how mild TBI (mTBI) influences PD-associated pathologies in preclinical models.
- To explore the role of injury-induced immune signaling in exacerbating neurodegeneration.
- To identify potential therapeutic targets for mitigating TBI-induced PD risk.
Main Methods
- Utilized preclinical mouse models of mTBI and PD.
- Analyzed gene expression changes in dopaminergic (DA) neurons post-mTBI.
- Assessed the impact of mTBI on DA neuron degeneration and Lewy body (LB) pathology spread.
- Investigated the effects of adaptive immune cell depletion (T cells, B cells) on neurodegenerative outcomes.
Main Results
- mTBI upregulated genes related to neuroinflammation, adaptive immunity, and PD in DA neurons.
- mTBI led to DA neuron degeneration in the substantia nigra (SN) and increased LB pathology spread.
- Depletion of T cells or B cells, or absence of mature lymphocytes, improved DA neuron survival and reduced pathology spread.
- Evidence suggests chronic peripheral immune cell infiltration negatively impacts DA neurons and alpha-synuclein (α-syn) propagation.
Conclusions
- mTBI can worsen PD pathology by activating neuroinflammatory and adaptive immune responses.
- Adaptive immune cells infiltrating the central nervous system (CNS) contribute to DA neuron vulnerability and α-syn pathology.
- Targeting peripheral immune cell infiltration presents a potential therapeutic strategy to reduce PD risk after brain injury.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
The cephalic phase is a conditioned or learned response to familiar foods. Our appetite or desire for a particular food modifies the preparatory responses directed by the brain. Individuals may produce more saliva and stomach...
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...